FDA NDC Directory · JSON-LD · Markdown

Ondansetron

NDC 80425-0227 · HUMAN PRESCRIPTION DRUG · TABLET, ORALLY DISINTEGRATING

Labeler / ManufacturerAdvanced Rx Pharmacy of Tennessee, LLC
Marketing categoryAbbreviated NDA (generic) · App ANDA078152
Dosage form / routeTABLET, ORALLY DISINTEGRATING · ORAL
Active ingredientsONDANSETRON (8 mg/1)
Marketing started20230111
Package count1

External sources

Source: openFDA. Public-domain (CC0).